Recently, many reports have drawn attention from the roles of IL-33/ST2L to their effects in facilitating communication between tumor cells and immune cells within the tumor microenvironment (TME), significantly influencing the remodeling of immunosuppressive TME [5–8]. This evidence concerns the gene IL33 and neoplasm.